Cytokine Marker Measurement in Human Neuroblastoma Cells with Supersensitive and Multiplex Assay: MUSTag Technology

Background: Recently, various sets of protein ­biomarkers have been discovered in important diseases such as cancers, brain stroke and heart attack. However, clinical validation is difficult and time-consuming by individual assays or because of very low concentrations at early stages of the diseases. We have developed assay technology through an innovative modification of the immuno-PCR method for the super-sensitive and multiplex detection of target biomarkers.